Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.

Journal:

Journal of Clinical Oncology

Published:

2025-06-01

DOI:

10.1200/jco-25-00759

Affiliations:

18

Authors:

19

Go to article

Institutions	Authors	Share
Mayo Clinic, United States of America (USA)	2.000000	0.11
UPMC Hillman Cancer Center (UPCI), United States of America (USA)	2.000000	0.11
Nevada Cancer Specialists, United States of America (USA)	1.000000	0.05
The Winship Cancer Institute of Emory University, United States of America (USA)	1.000000	0.05
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	1.000000	0.05
Hollings Cancer Center, MUSC, United States of America (USA)	1.000000	0.05
UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC), United States of America (USA)	1.000000	0.05
Case Western Reserve University (CWRU), United States of America (USA)	1.000000	0.05
University of Michigan Rogel Cancer Center, United States of America (USA)	1.000000	0.05
Carle Foundation Hospital, United States of America (USA)	1.000000	0.05
The University of Chicago Medicine, United States of America (USA)	1.000000	0.05
Fox Chase Cancer Center (FCCC), United States of America (USA)	1.000000	0.05
OU Health Sciences Center (OUHSC), United States of America (USA)	1.000000	0.05
The University of Texas MD Anderson Cancer Center, United States of America (USA)	1.000000	0.05
University of Arizona Cancer Center (UACC), United States of America (USA)	1.000000	0.05
VCU Medical Center, United States of America (USA)	1.000000	0.05
Dana-Farber/Partners CancerCare, United States of America (USA)	1.000000	0.05

Interested in Clinical Sciences?